Who
Jennifer Humes
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Roivant Sciences.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $768K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Mar 2025
- Last trade
- 20 Sep 2026
- Last filed
- 22 Sep 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Sep 2026filed 22 Sep 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $154K3,880 at $39.77 | filing |
| 20 Sep 2026filed 22 Sep 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $154K3,880 at $39.77 | filing |
| 20 Jun 2026filed 23 Jun 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $113K3,582 at $31.43 | filing |
| 20 Jun 2026filed 23 Jun 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $113K3,582 at $31.43 | filing |
| 20 Apr 2026filed 22 Apr 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code A | —29,173 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,157 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,157 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code A | —29,173 at $0.00 | filing |
| 8 Apr 2026filed 10 Apr 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $384K13,538 at $28.37 | filing |
| 8 Apr 2026filed 10 Apr 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $384K13,538 at $28.37 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $402K14,526 at $27.70 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $402K14,526 at $27.70 | filing |
| 20 Mar 2025filed 24 Mar 2025 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,108 at $0.00 | filing |
| 20 Mar 2025filed 24 Mar 2025 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code A | —112,255 at $0.00 | filing |
News
Head to Head Analysis: Roivant Sciences (NASDAQ:ROIV) vs. Pharming Group (NASDAQ:PHAR)ROIV · dailypolitical.com · 14 Oct 2026Analyzing Roivant Sciences (NASDAQ:ROIV) and Krystal Biotech (NASDAQ:KRYS)ROIV · themarketsdaily.com · 12 Oct 2026Reviewing Janux Therapeutics (NASDAQ:JANX) & Roivant Sciences (NASDAQ:ROIV)ROIV · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Jennifer Humes; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.